Capital International Investors
NVO

Capital International Investors’s Novo Nordisk NVO Stock Holding History

Capital International Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425M Buy
11,795,850
+584,744
+5% +$27.7M 0.1% 161
2025
Q4 		$572M Sell
11,211,106
-6,502,318
-37% -$333M 0.09% 164
2025
Q3 		$983M Buy
17,713,424
+6,092,192
+52% +$357M 0.16% 109
2025
Q2 		$800M Buy
11,621,232
+2,109,687
+22% +$144M 0.14% 131
2025
Q1 		$660M Buy
9,511,545
+2,757,125
+41% +$228M 0.13% 140
2024
Q4 		$580M Sell
6,754,420
-204,594
-3% -$22.1M 0.11% 151
2024
Q3 		$835M Sell
6,959,014
-2,080
-0% -$277K 0.16% 130
2024
Q2 		$1B Sell
6,961,094
-124,239
-2% -$16.5M 0.21% 105
2024
Q1 		$910M Sell
7,085,333
-29,598
-0.4% -$3.52M 0.18% 114
2023
Q4 		$736M Buy
7,114,931
+1,297,536
+22% +$128M 0.17% 125
2023
Q3 		$532M Sell
5,817,395
-1,133,377
-16% -$99.8M 0.13% 151
2023
Q2 		$551M Sell
6,950,772
-408,626
-6% -$33.4M 0.13% 157
2023
Q1 		$583M Sell
7,359,398
-5,081,752
-41% -$360M 0.15% 150
2022
Q4 		$842M Sell
12,441,150
-118,568
-0.9% -$6.95M 0.23% 114
2022
Q3 		$628M Buy
12,559,718
+116,136
+0.9% +$6.22M 0.18% 131
2022
Q2 		$689M Buy
12,443,582
+1,792,482
+17% +$99.5M 0.19% 124
2022
Q1 		$596M Sell
10,651,100
-654,986
-6% -$33.6M 0.14% 158
2021
Q4 		$631M Buy
11,306,086
+358,098
+3% +$19.4M 0.13% 152
2021
Q3 		$526M Buy
10,947,988
+262,212
+2% +$12.7M 0.12% 163
2021
Q2 		$448M Buy
10,685,776
+541,034
+5% +$21M 0.1% 183
2021
Q1 		$343M Buy
10,144,742
+707,566
+7% +$25.2M 0.09% 198
2020
Q4 		$330M Buy
9,437,176
+273,534
+3% +$9.45M 0.09% 191
2020
Q3 		$320M Sell
9,163,642
-391,986
-4% -$13.1M 0.1% 177
2020
Q2 		$313M Buy
9,555,628
+5,202,916
+120% +$166M 0.1% 168
2020
Q1 		$131M Buy
4,352,712
+563,040
+15% +$16.8M 0.05% 201
2019
Q4 		$110M Buy
3,789,672
+1,116,892
+42% +$30.9M 0.04% 225
2019
Q3 		$69.1M Buy
2,672,780
+1,041,794
+64% +$26.3M 0.03% 250
2019
Q2 		$41.6M Buy
1,630,986
+1,160
+0.1% +$28.7K 0.02% 286
2019
Q1 		$42.6M Hold
1,629,826
– – 0.02% 288
2018
Q4 		$37.5M Sell
1,629,826
-4
-0% -$89 0.02% 271
2018
Q3 		$38.4M Buy
1,629,830
+727,000
+81% +$17.7M 0.02% 286
2018
Q2 		$20.8M Hold
902,830
– – 0.02% 204
2018
Q1 		$22.2M Buy
902,830
+2
+0% +$53 0.03% 209
2017
Q4 		$24.2M Hold
902,828
– – 0.03% 213
2017
Q3 		$21.7M Sell
902,828
-190,400
-17% -$4.3M 0.03% 222
2017
Q2 		$23.4M Buy
1,093,228
+28
+0% +$565 0.03% 219
2017
Q1 		$18.7M Sell
1,093,200
-4,544,200
-81% -$79.1M 0.03% 226
2016
Q4 		$101M Buy
5,637,400
+256,000
+5% +$4.64M 0.15% 151
2016
Q3 		$112M Buy
5,381,400
+1,517,200
+39% +$37.6M 0.16% 143
2016
Q2 		$104M Sell
3,864,200
-1,830,000
-32% -$50.2M 0.15% 150
2016
Q1 		$154M Hold
5,694,200
– – 0.24% 120
2015
Q4 		$165M Hold
5,694,200
– – 0.26% 114
2015
Q3 		$154M Hold
5,694,200
– – 0.28% 110
2015
Q2 		$156M Buy
5,694,200
+1,686,000
+42% +$47.4M 0.26% 124
2015
Q1 		$107M Hold
4,008,200
– – 0.19% 133
2014
Q4 		$84.8M Buy
4,008,200
+1,640,000
+69% +$36.6M 0.17% 147
2014
Q3 		$56.4M Buy
2,368,200
+343,200
+17% +$7.9M 0.14% 153
2014
Q2 		$46.8M Hold
2,025,000
– – 0.12% 158
2014
Q1 		$46.2M Buy
+2,025,000
New +$43.1M 0.12% 163

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors's NVO Position: Q1 2026 in Review

Capital International Investors increased its Novo Nordisk (NVO) stake by 5.2% in Q1 2026, buying an estimated $27.7M and bringing the position to 11,795,850 shares worth $425M. The position accounts for 0.1% of the portfolio, ranked #161.

Capital International Investors first reported a position in NVO in Q1 2014 and has held it in 49 quarters since. The position peaked at $1B in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Capital International Investors held 11,795,850 shares of Novo Nordisk worth $425M as of Q1 2026.
  • Capital International Investors bought 584,744 Novo Nordisk shares in Q1 2026, an estimated $27.7M.
  • Novo Nordisk made up 0.1% of Capital International Investors's portfolio in Q1 2026, its #161 holding.
  • Capital International Investors first reported a position in Novo Nordisk in Q1 2014 and has held it in 49 quarters since.
  • Capital International Investors's Novo Nordisk position peaked at $1B in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.